-
-
-
-
-
-
-
Leqembi® Iqlik™ PDUFA date updated to August 24 in the U.S.
-
-
-
-
-
-
-
FDA approves IV maintenance dosing of Leqembi® (lecanemab-irmb) for the treatment of early Alzheimer's Disease in the US
-
15,735 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

